News tagged with monoclonal antibodies
Related topics: breast cancer , cancer , cancer cells , antibodies , immune system
Researchers find potential key to new treatment for mantle cell lymphoma
Researchers at Moffitt Cancer Center and colleagues have demonstrated that the inhibition of signal transducer and activator of transcription 3 (STAT3) in mouse models of mantle cell lymphoma (MCL), an aggressive and incurable ...
Cancer
Jul 18, 2012 |
not rated yet |
0
|
Mayo Clinic uses new approach to reverse multiple sclerosis in mice models
Mayo Clinic researchers have successfully used smaller, folded DNA molecules to stimulate regeneration and repair of nerve coatings in mice that mimic multiple sclerosis (MS). They say the finding, published today in the ...
Medical research
Jun 28, 2012 |
not rated yet |
0
|
Researchers develop novel anti-body vaccine that blocks addictive nicotine chemicals from reaching the brain
Researchers at Weill Cornell Medical College have developed and successfully tested in mice an innovative vaccine to treat nicotine addiction.
Medical research
Jun 27, 2012 |
5 / 5 (7) |
7
|
Advanced cancers destined to recur after treatment with single drugs that 'target' tumor cells: study
Targeted cancer cell therapies using man-made proteins dramatically shrink many tumors in the first few months of treatment, but new research from Johns Hopkins scientists finds why the cells all too often become resistant, ...
Cancer
Jun 13, 2012 |
4 / 5 (1) |
0
|
Molecular imaging signals new treatment protocol for kidney cancer
Research revealed at the Society of Nuclear Medicine's 2012 Annual Meeting explores treatment with a newly developed type of radioimmunotherapy used for treating a resistant form of kidney cancer. The agent is able to hone ...
Cancer
Jun 11, 2012 |
not rated yet |
0
New immune therapy shows promise in kidney cancer
An antibody that helps a person's own immune system battle cancer cells shows increasing promise in reducing tumors in patients with advanced kidney cancer, according to researchers at Beth Israel Deaconess Medical Center.
Cancer
Jun 04, 2012 |
not rated yet |
0
Immune therapies: The next frontier in battle against atherosclerosis
New strategies injecting cardiovascular disease (CVD) patients with vaccines and monoclonal antibodies to combat atherosclerosis could soon change the treatment landscape of heart disease. Both approaches, Professor Jan Nilsson ...
Cardiology
Mar 30, 2012 |
5 / 5 (1) |
0
|
Monthly shot lowers cholesterol 66 percent: study
A monthly injection of an experimental drug made by the US biotech firm Amgen reduced patients' cholesterol by up to 66 percent, according to a small study described at a US cardiology conference.
Cardiology
Mar 26, 2012 |
5 / 5 (2) |
5
Statin alternative looks promising in early trials
(HealthDay) -- Administration of REGN727, a monoclonal antibody to proprotein convertase subtilisin/kexin 9 (PCSK9), significantly reduces low-density lipoprotein (LDL) cholesterol levels, according to the ...
Cardiology
Mar 22, 2012 |
3 / 5 (1) |
1
|
Discovery offers insight into treating viral stomach flu
Twenty million Americans get sick from norovirus each year according to data released last week by the Centers for Disease Control (CDC). Often called vomiting illness, it can spread rapidly on cruise ships, ...
Medical research
Mar 21, 2012 |
5 / 5 (1) |
0
|
Response rate high for some patients with metastatic melanoma treated with vemurafenib
An international team of researchers from the United States and Australia, including researchers at Moffitt Cancer Center in Tampa, Fla., have found that the oral BRAF inhibitor vemurafenib (PLX4032) when tested in a phase ...
Cancer
Mar 16, 2012 |
5 / 5 (1) |
0
|
New research could significantly reduce the need for clinical animal testing
University of Southampton researchers are investigating innovative methods of testing drugs that will reduce the need for involving animals.
Immunology
Mar 08, 2012 |
1 / 5 (1) |
0
Rituximab possible treatment option for patients with primary biliary cirrhosis
An open-label study of rituximab, a monoclonal antibody for human CD20, was shown to be safe in patients with primary biliary cirrhosis (PBC) who had an incomplete response to the standard ursodeoxycholic acid (UDCA) therapy, ...
Diseases, Conditions, Syndromes
Feb 02, 2012 |
not rated yet |
0
Study identifies a cause of resistance to colon cancer treatment
Doctors and researchers of Hospital del Mar and its research institute, the IMIM, have lead a study describing a new pharmacological resistance to cancer. This new mechanism is a mutation in an oncogene called EGFR (epidermal ...
Cancer
Jan 22, 2012 |
5 / 5 (1) |
0
A new way to stimulate the immune system and fight infection
A study carried out by Eric Vivier and Sophie Ugolini at the Marseille-Luminy Centre for Immunology has just reveal a gene in mice which, when mutated, can stimulate the immune system to help fight against tumors and viral ...
Medical research
Jan 20, 2012 |
5 / 5 (3) |
0
